UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients

Journal of clinical oncology, 2004-03, Vol.22 (5), p.890-899

2004

Volltextzugriff (PDF)

Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer

Journal of clinical oncology, 2000-01, Vol.18 (1), p.136-147

2000

Volltextzugriff (PDF)

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Annals of oncology, 2002-02, Vol.13 (2), p.258-266

2002

Volltextzugriff (PDF)

Factors Predicting for Efficacy and Safety of Docetaxel in a Compassionate-Use Cohort of 825 Heavily Pretreated Advanced Breast Cancer Patients

Journal of clinical oncology, 2000-02, Vol.18 (3), p.562-573

2000

Volltextzugriff (PDF)

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

Annals of oncology, 1999-06, Vol.10 (6), p.663-669

1999

Volltextzugriff (PDF)

9163 Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)

European journal of cancer supplements, 2009, Vol.7 (2), p.554-554

2009

Volltextzugriff (PDF)

Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports

Annals of oncology, 1997-10, Vol.8 (10), p.1049-1051

1997

Volltextzugriff (PDF)

704 POSTER A phase I dose escalation and pharmacokinetic study of BIBF 1120, a novel tyrosine kinase inhibitor against VEGFR, PDGFR and FGFR, in combination with docetaxel in advanced chemonaive hormone refractory prostate cancer patients (HRPC)

European journal of cancer supplements, 2007, Vol.5 (4), p.108-108

2007

Volltextzugriff (PDF)

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer

Annals of oncology, 1999-05, Vol.10 (5), p.553-560

1999

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors

Annals of oncology, 2004-07, Vol.15 (7), p.1123-1129

2004

Volltextzugriff (PDF)

[18F]-FDG positron imaging in clinical management of lymphoma patients

Critical reviews in oncology/hematology, 2001-06, Vol.38 (3), p.193-221

2001

Volltextzugriff (PDF)

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer

European journal of cancer (1990), 1997-08, Vol.33 (9), p.1400-1406

1997

Volltextzugriff (PDF)

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients

Annals of oncology, 1999-03, Vol.10 (3), p.351-354

1999

Volltextzugriff (PDF)

Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells

European journal of cancer (1990), 1995-06, Vol.31 (6), p.953-963

1995

Volltextzugriff (PDF)

Irinotecan-induced immune thrombocytopenia

Annals of oncology, 1998-04, Vol.9 (4), p.453-455

1998

Volltextzugriff (PDF)

Docetaxel in combination with doxorubicin or vinorelbine

European journal of cancer (1990), 1997-08, Vol.33, p.S20-S22

1997

Volltextzugriff (PDF)

Anthracyclin-related leukaemias after breast cancer (BC) adjuvant/neoadjuvant treatment: Dose relationship?

European journal of cancer (1990), 1999-09, Vol.35, p.S332-S333

1999

Volltextzugriff (PDF)

Parma International Protocol: Pilot Study of DHAP Followed by Involved-Field Radiotherapy and BEAC With Autologous Bone Marrow Transplantation

Blood, 1991-04, Vol.77 (7), p.1587-1592

1991

Volltextzugriff (PDF)

La chimiothérapie première permet-elle réellement d’augmenter le taux de conservation mammaire ?

Cancer radiothérapie, 2004-02, Vol.8 (1), p.48-53

2004

Volltextzugriff (PDF)

P134 - Réactions cutanéo-phanériennes aux anti-EGFR : acné, oui, mais aussi éruptions eczématiformes, photosensibilité, trichomégalie et aphtes

Annales de dermatologie et de vénéréologie, 2005-10, Vol.132, p.152-152

2005

Volltextzugriff (PDF)

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

Biomedicine & pharmacotherapy, 1989, Vol.43 (4), p.237-250

1989

Volltextzugriff (PDF)

Pharmacokinetics (PK) of irofulven using two different intermittent dosing schedules as a 30 minute (MIN) infusion in advanced solid tumors (AST): Preliminary data

European journal of cancer (1990), 2001-04, Vol.37, p.S68-S68

2001

Volltextzugriff (PDF)

Phase I study of MGI 114 (Irofulven) given as either D1, D8 q3 weeks or D1, D5 q4 weeks schedule (sch) as a 30 minute infusion in advanced solid tumors (AST): preliminary results

European journal of cancer (1990), 2001-04, Vol.37, p.S72-S73

2001

Volltextzugriff (PDF)

Pharmacokinetics (PK) of irofulven using three different intermittent 5-minutes (MIN) infusion dosing schedules (sch) in advanced solid tumors (AST): Final results

European journal of cancer (1990), 2001-04, Vol.37, p.S66-S67

2001

Volltextzugriff (PDF)

Consistent evidence of activity of ecteinascidin (ET-743) in pretreated, advanced soft tissue sarcoma (ASTS): results from a pooled analysis of three pivotal phase II clinical trials (p2ct) and safety profile of a 24 h infusion schedule

European journal of cancer (1990), 2001-04, Vol.37, p.S34-S34

2001

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(75)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(29)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Female
(22)
Middle Aged
(22)
Oncology
(20)
Adult
(19)
Biological And Medical Sciences
(19)
Male
(19)
Medical Sciences
(19)
Aged
(15)
Pharmacology. Drug Treatments
(13)
Antineoplastic Agents
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Organoplatinum Compounds - Administration & Dosage
(8)
Chemotherapy
(7)
Organoplatinum Compounds - Adverse Effects
(7)
Oxaliplatin
(7)
Prognosis
(7)
Treatment Outcome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients

Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Factors Predicting for Efficacy and Safety of Docetaxel in a Compassionate-Use Cohort of 825 Heavily Pretreated Advanced Breast Cancer Patients

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

9163 Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)

Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports

704 POSTER A phase I dose escalation and pharmacokinetic study of BIBF 1120, a novel tyrosine kinase inhibitor against VEGFR, PDGFR and FGFR, in combination with docetaxel in advanced chemonaive hormone refractory prostate cancer patients (HRPC)

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer

Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors

[18F]-FDG positron imaging in clinical management of lymphoma patients

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients

Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells

Irinotecan-induced immune thrombocytopenia

Docetaxel in combination with doxorubicin or vinorelbine

Anthracyclin-related leukaemias after breast cancer (BC) adjuvant/neoadjuvant treatment: Dose relationship?

Parma International Protocol: Pilot Study of DHAP Followed by Involved-Field Radiotherapy and BEAC With Autologous Bone Marrow Transplantation

La chimiothérapie première permet-elle réellement d’augmenter le taux de conservation mammaire ?

P134 - Réactions cutanéo-phanériennes aux anti-EGFR : acné, oui, mais aussi éruptions eczématiformes, photosensibilité, trichomégalie et aphtes

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

Pharmacokinetics (PK) of irofulven using two different intermittent dosing schedules as a 30 minute (MIN) infusion in advanced solid tumors (AST): Preliminary data

Phase I study of MGI 114 (Irofulven) given as either D1, D8 q3 weeks or D1, D5 q4 weeks schedule (sch) as a 30 minute infusion in advanced solid tumors (AST): preliminary results

Pharmacokinetics (PK) of irofulven using three different intermittent 5-minutes (MIN) infusion dosing schedules (sch) in advanced solid tumors (AST): Final results

Consistent evidence of activity of ecteinascidin (ET-743) in pretreated, advanced soft tissue sarcoma (ASTS): results from a pooled analysis of three pivotal phase II clinical trials (p2ct) and safety profile of a 24 h infusion schedule

Suchergebnisse filtern